Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

3yrs ago Private Equity privateequitywire Views: 386

Evolution Equity Partners leads Series C round in Quantexa

Submitted By Karin Wasteson | 23/07/2020 - 4:58pm -

Evolution Equity Partners has led a Series C round in Quantexa, a decision intelligence software company that enables organisations to make better decisions, raising a further USD64.7 million in funding.

Existing investors AlbionVC, HSBC, and Dawn Capital also joined the round. In addition to British Patient Capital, ABN AMRO Ventures joined as a new investor alongside previous investor Accenture Ventures. British Patient Capital had a prior exposure to Quantexa via its commitment to Dawn Capital’s third fund.

“This first British Patient Capital direct investment alongside Dawn Capital, one of our fund managers, is a significant step forward to achieving our long-term vision for more home-grown and fully-funded high growth companies to fulfil their potential to be players on the global stage,” said Catherine Lewis La Torre, CEO British Patient Capital.

“We have followed Quantexa’s development closely and given its current client base and growth potential, see a compelling investment opportunity,” she added.

CDI, which Quantexa uses, is an approach to data that gives organisations the ability to join multiple internal and external data sets. The funding is intended to accelerate Quantexa’s growth across the North America, Europe and Asia-Pacific regions, and to grow its partner ecosystem.

Vishal Marria, CEO at Quantexa, said he is seeing a huge demand for the platform to support multiple applications across core markets in financial services and within new industry sectors.

“This investment will accelerate our product innovation roadmap and enable us to invest further into Europe, North America and Asia Pacific regions, as well as expand into new locations,” he added.

This new funding round follows a USD22.7 million Series B round in August 2018, bringing total funds raised to date to USD90 million. Since its inception in 2016, Quantexa has built a client base that supports thousands of users within organisations including HSBC, Standard Chartered Bank and Accenture.
 

Tags Deals & Transactions Investments Technology & software solutions

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.